Skip to main content
Premium Trial:

Request an Annual Quote

NSF Seeks Proposals for $8M Integrative Biological Research Program

NEW YORK, July 2 (GenomeWeb News) - The US National Science Foundation is seeking proposals for an $8 million program, frontiers in integrative biological research, according to a program announcement posted on its website yesterday.


This effort, the third FIBR program "supports integrative research that addresses major questions in the biological sciences," Ithe announcement states. It specifically encourages research that involves "integrating the scientific concepts and research tools from across disciplines including biology, math and the physical sciences, engineering, social sciences and the information sciences." Research looking at specific diseases is not supported under the program.


Eligibility is limited to US academic institutions and non-profit research organizations as well as consortia of these organizations. The NSF plans to make up to eight awards in FY 2005. Preliminary proposals are due October 4, 2004, and final proposals are due February 16, 2005. For more information,  click here.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.